Table 3 Targeted DMPs analyses of treatment responders at T1 (pre-treatment) vs T2 (post-treatment).

From: Distinct saliva DNA methylation profiles in relation to treatment outcome in youth with posttraumatic stress disorder

Responders T1 VS T2

Probe

Chr

Position

p-value

DeltaBeta

Gene

Gene Feature

cg18090898

7

30739695

0.0003*

0.0802

CRHR2

1stExon

cg17700633

19

13263997

0.0018

0.0187

IER2

5’UTR

cg14849556

2

24991672

0.0052

0.0382

NCOA1

3’UTR

cg08550353

6

1,34E + 08

0.0227

−0.0397

SGK1

TSS1500;Body

cg26269677

5

76251688

0.0231

−0.0546

CRHBP

Body

  1. Top 5 Targeted DMPs analyses of treatment responders at T1 (pre-treatment) vs T2 (post-treatment).DMPs: Differently methylated positions; chr: chromosome; p-value; DeltaBeta: delta differences between groups, based on average β-value: Genome build (HG19), Gene: UCSC Reference Gene Name; Gene feature: gene feature according Illumina manifest. Bonferonni corrected P-value 0.0003 *indicates a significant result.
Back to article page